BlackRock’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $165K | Sell |
|
|||||
|
2025
Q2 | $500K | Sell |
|
|||||
|
2025
Q1 | $735K | Sell |
|
|||||
|
2024
Q4 | $834K | Buy |
|
|||||
|
2024
Q3 | $1.02M | Buy |
|
|||||
|
2024
Q2 | $1.04M | Buy |
|
|||||
|
2024
Q1 | $1.16M | Sell |
|
|||||
|
2023
Q4 | $889K | Sell |
|
|||||
|
2023
Q3 | $664K | Sell |
|
|||||
|
2023
Q2 | $911K | Buy |
|
|||||
|
2023
Q1 | $830K | Sell |
|
|||||
|
2022
Q4 | $895K | Sell |
|
|||||
|
2022
Q3 | $1.34M | Sell |
|
|||||
|
2022
Q2 | $1.78M | Sell |
|
|||||
|
2022
Q1 | $2.79M | Sell |
|
|||||
|
2021
Q4 | $3.35M | Buy |
|
|||||
|
2021
Q3 | $4.83M | Buy |
|
|||||
|
2021
Q2 | $3.76M | Sell |
|
|||||
|
2021
Q1 | $2.16M | Buy |
|
|||||
|
2020
Q4 | $2.1M | Buy |
|
|||||
|
2020
Q3 | $1.16M | Sell |
|
|||||
|
2020
Q2 | $1.42M | Sell |
|
|||||
|
2020
Q1 | $1.29M | Buy |
|
|||||
|
2019
Q4 | $2.17M | Buy |
|
|||||
|
2019
Q3 | $360K | Sell |
|
|||||
|
2019
Q2 | $560K | Sell |
|
|||||
|
2019
Q1 | $2.55M | Sell |
|
|||||
|
2018
Q4 | $2.04M | Sell |
|
|||||
|
2018
Q3 | $11.7M | Buy |
|
|||||
|
2018
Q2 | $19.9M | Buy |
|
|||||
|
2018
Q1 | $13M | Buy |
|
|||||
|
2017
Q4 | $6.88M | Sell |
|
|||||
|
2017
Q3 | $11.9M | Buy |
|
|||||
|
2017
Q2 | $11.9M | Buy |
|
|||||
|
2017
Q1 | $6.36M | Buy |
|
|||||
|
2016
Q4 | $18K | Buy |
|